The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.80
Bid: 106.60
Ask: 107.20
Change: 1.40 (1.34%)
Spread: 0.60 (0.563%)
Open: 107.20
High: 110.60
Low: 105.00
Prev. Close: 104.40
SAGA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update in relation to travel advice from the Gov't

13 Mar 2020 07:00

RNS Number : 0219G
SAGA PLC
13 March 2020
 

13 March 2020

 

This announcement contains inside information

Saga plc

("Saga" or "the Group")

Update in relation to travel advice from the Government

Saga notes the updated travel advice from the Government which advises people aged 70 and over and those with pre-existing health conditions against cruise ship travel at this time.

The health and safety of customers and colleagues is our number one priority. We have, therefore, made the decision to temporarily suspend operations of our Cruises until 1 May 2020. Our customer service teams will be in contact with Cruise customers who were due to travel in the next six weeks to offer them either a full refund or a credit for a future departure.

Demand for our Cruises has been very positive, with bookings of around 80% of the full year revenue target. While cancellations had increased in recent weeks, as of 11 March 2020, the average booked load factor for the remaining five Cruise departures in March was 79% and the average booked load factor for five April departures was 85%.

Financial impact

It is estimated that a cessation of Cruise trading for the next 6 weeks will reduce Cruise profit before tax by between £10m and £15m. Related advance customer receipts for this period are £22m.

While the travel environment remains uncertain, the Group continues to have significant available liquidity, underpinned by a £100m undrawn revolving credit facility, £33m of cash at the end of February and the strong cash generation of the Insurance business. As previously noted, the insurance business is not expected to be significantly impacted by COVID-19 and has had a good start to the current financial year. The two disposals recently announced are also expected to generate an additional £37m of cash proceeds in the first half.

There are a range of further mitigating actions the Group will take including additional cost efficiencies and reducing discretionary spend. 

ENDS

For further information please contact:

Saga plc

Mark Watkins, Director of Investor Relations

 

Tel: 07738 777 479

Email: mark.watkins@saga.co.uk

 

Headland

Susanna Voyle

Henry Wallers

 

 

Tel: 020 3805 4822

Email: saga@headlandconsultancy.com 

 

 

Notes to editors

About Saga

Saga is a specialist in the provision of products and services for life after 50. The Saga brand is one of the most recognised and trusted brands in the UK and is known for its high level of customer service and its high quality, award winning products and services including cruises and holidays, insurance, personal finance and publishing. www.saga.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGPURCWUPUPWP
Date   Source Headline
17th Apr 20247:00 amRNSPreliminary Results
30th Jan 20247:00 amRNSTrading Update
26th Jan 20247:00 amRNSResponse to Media Coverage
15th Jan 20244:52 pmRNSHolding(s) in Company
21st Dec 20234:43 pmRNSHolding(s) in Company
21st Dec 20234:39 pmRNSDirector/PDMR Shareholding
21st Dec 20233:44 pmRNSDirectorate Change
8th Dec 202312:53 pmRNSHolding(s) in Company
28th Nov 20237:00 amRNSDirectorate Change
20th Nov 20234:00 pmRNSHolding(s) in Company
2nd Nov 20232:44 pmRNSDirector/PDMR Shareholding
17th Oct 202311:53 amRNSHolding(s) in Company
9th Oct 20237:00 amRNSDirectorate Change
27th Sep 20237:01 amRNSDirectorate Change
27th Sep 20237:00 amRNSInterim Results
9th Aug 20234:47 pmRNSDirector/PDMR Shareholding
9th Aug 20234:44 pmRNSTotal Voting Rights
1st Aug 20233:03 pmRNSIssue of Equity
26th Jul 20238:37 amRNSChange of Registered Office
22nd Jun 20232:38 pmRNSHolding(s) in Company
20th Jun 20233:53 pmRNSResults of 2023 Annual General Meeting
20th Jun 20237:00 amRNSAGM Trading Update
13th Jun 20235:00 pmRNSDirector/PDMR Shareholding
30th May 20232:19 pmRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSNotice of AGM
18th Apr 20237:00 amRNSAnnual Report and Accounts and Strategic Report
4th Apr 20237:00 amRNSPreliminary Results
2nd Mar 20239:10 amRNSTermination of discussions with Open Insurance
10th Feb 20237:00 amRNSResponse to Media Coverage
24th Jan 20237:01 amRNSCapital Markets Event
24th Jan 20237:00 amRNSTrading Update
23rd Jan 20237:00 amRNSResponse to Media Coverage
28th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20227:00 amRNSDirectorate Change
17th Nov 20222:47 pmRNSHolding(s) in Company
17th Nov 20229:00 amRNSEstablishment of New Committee
18th Oct 202210:15 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20227:00 amRNSInterim Results
23rd Aug 20227:00 amRNSDirectorate Change
18th Jul 20225:08 pmRNSDirector/PDMR Shareholding
8th Jul 202210:50 amRNSDirector/PDMR Shareholding
5th Jul 20224:19 pmRNSResult of 2022 AGM
5th Jul 20227:00 amRNSDirectorate Change
5th Jul 20227:00 amRNSTrading Update
30th May 20229:00 amRNSNotice of 2022 AGM
3rd May 20225:04 pmRNSDirector/PDMR Shareholding
31st Mar 20224:29 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.